Zobrazeno 1 - 10
of 144
pro vyhledávání: '"J, Alsenz"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 112:503-506
A clinical picture with recurrent (in some cases potentially fatal) edema of skin and internal organs based not on a hereditary C1 inhibitor deficiency, but an acquired loss of C1 inhibitor activity due to antibodies is described for the first time i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ead7bd568e9ab4b04ad1239d5d67b62d
https://doi.org/10.1055/s-2008-1068084
https://doi.org/10.1055/s-2008-1068084
Publikováno v:
Molecular Immunology. 42:657-663
C1-esterase inhibitor (C1-INH) was depleted from normal human serum (NHS) at 4 degrees C by affinity chromatography with a monoclonal anti-C1-INH antibody (mAb 13 E1) coupled to CNBr-activated Sepharose 4B. The C1-INH-depleted serum (C1-INH-depl-HS)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d762aa5db8f028b2082d3b0fa08300b
https://doi.org/10.1016/j.molimm.2004.09.025
https://doi.org/10.1016/j.molimm.2004.09.025
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Pharmaceutical research. 17(7)
This study was aimed at examining the extent and mechanism of uptake of cobalamin (Cbl)-conjugated peptides in vitro and in vivo.To enable acquisition of quantitative absorption data of Cbl-peptides, metabolically stable octapeptides (DP3), with (Cbl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5e41121ad661706bf388765f1051010f
https://pubmed.ncbi.nlm.nih.gov/10990201
https://pubmed.ncbi.nlm.nih.gov/10990201
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 6(4)
A recently developed, new theoretical absorption model for passive diffusion through biological membranes describing the dependency of membrane permeability on lipophilicity and molecular size, predicts different sigmoid-hyperbolic permeability-lipop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::24ff2a4f67514958ea161ea98dfcf4d3
https://pubmed.ncbi.nlm.nih.gov/9795088
https://pubmed.ncbi.nlm.nih.gov/9795088
Publikováno v:
Pharmaceutical research. 15(3)
To investigate in vitro the mechanisms involved in the gastro-intestinal absorption of the HIV protease inhibitor, saquinavir mesylate (Invirase), whose oral bioavailability is low, variable, and significantly increased by co-administration with rito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3484bcf31734a25e47d86e27574206f2
https://pubmed.ncbi.nlm.nih.gov/9563072
https://pubmed.ncbi.nlm.nih.gov/9563072
Publikováno v:
Pharmaceutical research. 14(10)
Protein aggregates are thought to be involved in the immunogenicity of recombinant proteins in humans. To probe human IFN-alpha formulations for the presence of soluble protein aggregates, enzyme-linked immunosorbent assays (ELISA) were developed.For
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fd7ff7f3e2b0a048aa2037410218b7d8
https://pubmed.ncbi.nlm.nih.gov/9358552
https://pubmed.ncbi.nlm.nih.gov/9358552
Publikováno v:
Pharmaceutical research. 14(10)
During long-term treatment of various malignant or viral diseases with IFN-alpha up to 20% of patients develop anti-IFN-alpha antibodies for as yet unknown reasons.To address this issue, a mouse model using Balb/C mice was established and the relevan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::00f38ea1e27ce0de5e8cd8d7d4c2284b
https://pubmed.ncbi.nlm.nih.gov/9358564
https://pubmed.ncbi.nlm.nih.gov/9358564